FindTrial
Sign In

Noninvasive Spinal Neuromodulation Enables Locomotor Recovery in Individuals With Cerebral Palsy

Noninvasive Spinal Neuromodulation Enables Locomotor Recovery in Individuals With Cerebral Palsy

Status
UNKNOWN
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT04882592
Enrollment
50
Registered
2021-05-12
Start date
2021-05-15
Completion date
2024-12-01
Last updated
2023-04-04

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Cerebral Palsy

Brief summary

Assessing the effects of noninvasive spinal cord neuromodulation on improving function in individuals with cerebral palsy

Interventions

DEVICESCiP

Noninvasive spinal cord neuromodulator

Sponsors

SpineX Inc.
Lead SponsorINDUSTRY

Study design

Allocation
NA
Intervention model
CROSSOVER
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
2 Years to 75 Years
Healthy volunteers
Yes

Inclusion criteria

* 1\) individuals above the age of 2 years of age and 2) diagnosed with cerebral palsy (CP). The

Exclusion criteria

included 1) children with selective dorsal root rhizotomy, 2) intramuscular Botox injection in the preceding 12 months, 3) current antispastic medications 4) unhealed fractures or contractures that would prevent them from performing functional tasks and 5) tendon lengthening surgeries.

Design outcomes

Primary

MeasureTime frame
Stepping overground or on a treadmill3 months
Gross Motor Functional Measure (GMFM)3 months

Countries

United States

Contacts

Primary ContactParag Gad, PhD
parag@spinex.co4082035061

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 13, 2026